Once a week subcutaneous administration of recombinant human erythropoietin (KRN5702) for predeposit autologous blood donation. A multi-institutional early phase II study.
暂无分享，去创建一个
T. Hotokebuchi | S. Inaba | Y. Sugioka | H. Moriya | Shigeru Tanaka | F. Takaku | Y. Ikeda | T. Juji | Koki Takahashi | M. Handa | S. Tachibana | Takashi Saito | H. Tsutsui | T. Sakamaki | Y. Shibata | T. Kurokawa | H. Matsumoto | K. Kaneda | Masaya Kawabata | I. Saikawa | Yutaka Yabe | N. Wakimoto | S. Asano | S. Minami | S. Morimoto | M. Ogino | Mitsuhiro Matsumoto